Top Quality Letrozole Femara for Breast Cancer

Top Quality Letrozole Femara for Breast Cancer

Informations de base:

Letrozole
CAS:112809-51-5
Formule moléculaire:C17H11N5
Masse moléculaire: 285.3
Apparence: White power
Essai:99.5%
Minimum order:100g
Supply ability: 5000kg/mois
Quality standard: USP32
Paiement:T/T, Western Union et Money Gram
Livraison:Dans les 24 heures après votre paiement
Paiement:T/T, Western Union et Money Gram
Livraison:Dans les 24 heures après votre paiement
Exprimer: SMU, DHL, Fedex, etc(porte à porte)

Description du produit:

Femara is a non-steroidal aromatase inhibitor (lowers estrogen production) used to treat breast cancer in postmenopausal women. It is often given to women who have been taking tamoxifen (Nolvadex, Soltamox) pour 5 années. Femara is available in generic form. Common side effects of Femara include hot flashes, perte de cheveux, joint/bone/muscle pain, fatigue, unusual sweating or night sweats, nausea, diarrhea, dizziness, trouble sleeping, drowsiness, weight gain, la faiblesse, flushing (warmth, rougeur, or tingly feeling), mal de tête, constipation, numbness/tingling/weakness/stiffness in your hand or fingers, or pain in your hand that spreads to your arm, wrist, forearm, or shoulder.

Femara is approved by the United States Food and Drug Administration (FDA) for the treatment of local or metastatic breast cancer that is hormone receptor positive or has an unknown receptor status in postmenopausal women.Femara is intended for use only by women who are no longer of childbearing age. Possible candidates must have already ceased to menstruate. It is often used in patients who have already undergone other cancer treatments, such as radiation, chemotherapy, and used other cancer drugs, like tamoxifen. This nonsteroidal aromatase inhibitor may help prevent any remaining cancer cells from spreading.

Applications of Letrozole/ Femara:

Femara est un type II (non stéroïdien) inhibiteur de l'aromatase de troisième génération. It’s primarily administered to halt the progression of breast cancer in women. It is generally used as part of an aggressive treatment in post-menopausal women, to fight and reverse the spread of breast cancer after other treatments (such as Tamoxifen therapy) has failed. It’s probably the most efficient product on the market for this purpose. Letrozole is very similar in both structure and action to its AI predecessor Arimidex. In women with breast cancer, it has been shown to reduce estrogen levels by 98% or more. Cependant, it’s use and benefits are not limited to eliminating estrogen in women.

For athletes and bodybuilders, it is a drug used to combat the estrogenic side effects of anabolic steroids water-retention, acne and gynocomastia. It will also raise testosterone levels because of the lowered estrogen in the body.
Letrozole is currently the most powerful aromatase inhibitor available. In the world of bodybuilding it is used to reduce or eliminate excess estrogen caused by the use of aromatizing steroids.
Femara is a drug used to combat the estrogenic side effects of anabolic steroids.